Natalija M. Farrell, PharmD, BCPS, DABAT, FAACT

Publications

• Published 2/17/2025

  Peterkin AF, Laks J, Farrell N, Weisenthal K, Taylor JL. Outpatient Alcohol Withdrawal Management in a Substance Use Disorder Bridge Clinic: An Opportunity for Low-barrier Engagement and Shared Decision-making. J Addict Med. 2025 Feb 17. PMID: 39961087.

  Read at: PubMed

• Published 11/4/2024

  Rozansky H, Christine PJ, Younkin M, Fox JM, Weinstein ZM, Suarez S, Stewart J, Farrell N, Taylor JL. Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital. Addict Sci Clin Pract. 2024 Nov 04; 19(1):77. PMID: 39497126.

  Read at: PubMed

• Published 6/30/2024

  Sarah Temi Sofeso Pharm.D, Emily Plasencia Pharm.D, Ana A. Safri Pharm.D., MBA, Cedric S. White Pharm.D, Natalija Mead Farrell Pharm.D, Jessica L. Corio Pharm.D, Danielle Kebadjian Lindale Pharm.D, Madeline Palmer M.D., Bryan J. Gendron Pharm.D. Pharmacist review of discharge antibiotics for urinary tract infections in the emergency department. J Am Coll Clin Pharm. 2024; 1-8.

  Read at: Custom

• Published 6/26/2024

  Laks J, Kim TW, Christine PJ, Evans J, Farrell NM, Kehoe J, Younkin M, Taylor JL. Treating Benzodiazepine Withdrawal in a Bridge Clinic. J Addict Med. 2024 Nov-Dec 01; 18(6):649-656. PMID: 38922639.

  Read at: PubMed

• Published 2/8/2024

  Shahlapour M, Singh S, Christine PJ, Laks J, Evans J, Farrell NM, Khan GK, Taylor JL, Rozansky H. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic. J Addict Med. 2024 May-Jun 01; 18(3):345-347. PMID: 38329815.

  Read at: PubMed

View All 21 Publications:   View Full Profile in BUMC